Home > Drug Search >
  • company_query: Beijing Wantai Bio-pharm
  •   > 
Drug Filter
Category:
chemistry (7) biology (20)
Status:
NDA Filing (1) Phase Ⅲ (6) Phase Ⅱ (12) Phase Ⅰ (8)
Clinical Stage:
Pending (2) Active (22) Discontinued (3)
Bio-Type:
Coagulation factor (2) Gene therapy (1) Vaccine (16) Recombinant cytokines (1)
Indication:
Squamous cell cancer (1) Atopic dermatitis (1) Clostridium difficile infection (1) HBV infection (1) Heart failure (1) HIV infection (2) Influenza virus infection (1) Melanoma (1) Multiple sclerosis (MS) (1) Onychomycosis (1) Ovarian cancer (1) Peptic ulcer (1) Perennial allergic rhinitis (1) Seasonal allergic rhinitis (1) Rotavirus infection (1) Tuberculosis (1) Ulcerative colitis (2) Head and neck cancer (1) Influenza A virus infections (1) Leg ulcer (1) Colorectal cancer (1) Diabetic foot ulcers (1) Cervical carcinoma (1) Hemophilia B (1) Condylomata acuminata (1) Renal carcinoma (1) Spinal cord injury (1) Allergic asthma (1) Coronary heart disease (1) Mesothelioma (1) Human papillomavirus infections (HPV) (2) Hemophilia (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top